adrenal crisis epidemiology forecast

DelveInsight’s ‘Adrenal Crisis– Epidemiology Forecast—2034’ report delivers an in-depth understanding of historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Adrenal Crisis Disease Understanding

Adrenal crisis refers to overwhelming and life-threatening adrenal insufficiency. The most common signs of adrenal crisis is shock (very low blood pressure with a loss of consciousness), dehydration, and an imbalance of sodium and potassium levels in the body. In some cases, shock is preceded by fever, nausea, vomiting, abdominal pain, weakness or fatigue, and confusion. Adrenal crisis usually occurs after an infection, trauma, or another stressor.

Adrenal Crisis Epidemiology

The Adrenal Crisis epidemiology division provides insights into the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed prevalence, trends, and assumptions.

Key Findings

The total prevalent cases of Adrenal Crisis patients are increasing by 7MM during the study period, i.e., 2021-2034.

The disease epidemiology covered in the report provides historical as well as forecasted Adrenal Crisis symptoms epidemiology segmented as the Total Diagnosed Prevalence, Gender-specific Cases, and Age-specific Cases. The report includes the prevalent scenario of Adrenal Crisis symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country-wise Adrenal Crisis Epidemiology

The epidemiology segment also provides the Adrenal Crisis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

• The prevalent cases of Adrenal Crisis associated in 7MM countries were 130,175 in 2021.
• As per the estimates, the United States has the largest prevalent population of Treatment-Resistant Depression
• Among the EU5 countries, Germany had the highest prevalent cases of Adrenal Crisis, followed by France and the UK. On the other hand, Spain had the lowest prevalent cases with 8,222 cases in 2021.

Scope of the Report

• The Adrenal Crisis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, molecular genetics, diagnosis, and treatment patterns.
• The Adrenal Crisis Epidemiology Report and Model provide an overview of Adrenal Crisis’s risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, the UK, and Japan).
• The report provides insight into Adrenal Crisis’s historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, the UK), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of the Adrenal Crisis.
• The report provides the segmentation of the Adrenal Crisis epidemiology by Total diagnosed prevalent cases of Adrenal Crisis in 7MM.
• The report provides the Adrenal Crisis epidemiology segmentation by the Gender-specific cases of Adrenal Crisis in 7MM.
• The report provides the Adrenal Crisis epidemiology segmentation by Age-specific cases of Adrenal Crisis in 7MM.

Report Highlights

• 10-year forecast of Adrenal Crisis epidemiology
• 7MM Coverage
• Total diagnosed prevalent cases of Adrenal Crisis
• Gender-specific cases of Adrenal Crisis cases
• Age-specific cases of Adrenal Crisis

KOL Views

We interview KOLs, and SMEs’ opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the indications.

Key Questions Answered

• What are the major factors that will drive the change in the patient population in Adrenal Crisis during the forecast period (2025-2034)?
• What are the key findings of the Adrenal Crisis epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2025-2034)?
• What would be the total number of Adrenal Crisis patients across the 7MM during the forecast period (2025-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?
• What are the disease risk, burdens, and unmet needs of Adrenal Crisis?
• What are the currently available treatments for Adrenal Crisis?

Reasons to buy

The Adrenal Crisis epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Adrenal Crisis market.
• Quantify patient populations in the global Adrenal Crisis market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Adrenal Crisis therapeutics in each market covered.
• Understand the magnitude of the Adrenal Crisis population by its Diagnosed prevalent cases.
• Understand the magnitude of the Adrenal Crisis population by its Gender-specific cases.
• Understand the magnitude of the Adrenal Crisis population by its Age-specific cases.
• The Adrenal Crisis epidemiology report and model were written and developed by Master and Ph.D. level epidemiologists.
• The Adrenal Crisis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over an 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population